Please find the agenda and downloadable slides decks below.
*Not all presenter slides were approved for release
Sonali Smith, MD
An Overview of the Diagnosis, Prognosis, and Evolving Treatments of Lymphoma
Why is Survivorship Important?
Pulmonary Long Term Toxicities
Cardiac Long Term Toxicities
Impact on Fertility
Survivorship Care Plans
Can We Identify High-Risk Follicular Lymphoma Before Starting Treatment?
Liquid Biopsies: Ready for Use in Lymphoma?
Why Does CAR T-Cell Therapy Fail?
Jane Churpek, MD, MS
Inherited Cancer Risk in Lymphoid Malignancies: What Do We Tell Our Patients?
Harnessing Epigenetics in the Treatment of Lymphoma
Targeting Apoptosis in Lymphoid Malignancies: More Than One Tool in the Shed?
John Seymour, MD, MPH
Using Molecular and Cytogenetic Information to Sequence Treatment in CLL in 2019
CAR T-Cell Therapy: Patient Identification and Integration Into Practice
Newly-Diagnosed Mantle Cell Lymphoma: Risk Stratification and Optimal Treatment
Pier Luigi Zinzani, MD, PhD
State of the Art Treatment Approach for Newly-Diagnosed T-Cell Lymphoma
Does Allogeneic Stem Cell Transplant Still Have a Role in Hodgkin Lymphoma?
Hodgkin Lymphoma: What Should We Recommend When ASCT Fails?
Should AYA Lymphomas Be Treated as Children or Adults?
Cardio-Oncology in Lymphoma: How and Why
Staging and Restaging in Lymphoma
Anthony Mato, MD, MSCE
The Growing Importance of Real World Evidence in the Management of Patients With CLL
Surrogate End Points in Lymphoma: When Do We Tell Patients, They Are “Cured”?
Treatment of Follicular Lymphoma Without Chemotherapy
Why We Should Treat FL With Chemotherapy